The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2025

Filed:

Jan. 28, 2024
Applicant:

Guangzhou Medical University, Guangdong, CN;

Inventors:

Du Feng, Guangdong, CN;

Wei Yi, Guangdong, CN;

Yongquan Hu, Guangdong, CN;

Junyuan Tang, Guangdong, CN;

Zhi Zhou, Guangdong, CN;

Haixia Zhuang, Guangdong, CN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4545 (2005.12); A61K 8/49 (2005.12); A61Q 19/02 (2005.12);
U.S. Cl.
CPC ...
A61K 31/4545 (2012.12); A61K 8/4933 (2012.12); A61Q 19/02 (2012.12);
Abstract

The present application belongs to the technical field of proteolysis-targeting chimeras (PROTACs), and discloses a PROTAC molecule and a preparation method and use thereof. A ligand for a target protein in the PROTAC molecule of the present application is a pyridine carboxylic acid-1-oxide derivative. In cell and zebrafish experiments, the PROTAC molecule exhibits no toxic and side effects at a drug concentration allowing a desired effect. At a cellular level, an inhibition level of the PROTAC molecule for human tyrosinase (TYR) reaches less than or equal to 1 μmol/L. The PROTAC molecule in the present application can significantly reduce the generation of melanin by degrading TYR, and has excellent solubility, safety, and efficacy and a low effective concentration.


Find Patent Forward Citations

Loading…